Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid during sleeve gastrectomy
NL-OMON28904Active, not recruiting
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in class III obesity, sponsored by None. Primary endpoints: Peroperative use of hemostatic staples, Decrease in hemoglobin after the procedure and 1 more. Started Jul 2020; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
class III obesity
Beyond the preview
Go deeper on NL-OMON28904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28904.